angiotensin ii has been researched along with quinazolines in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (25.86) | 18.7374 |
1990's | 7 (12.07) | 18.2507 |
2000's | 19 (32.76) | 29.6817 |
2010's | 17 (29.31) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Oates, HF | 1 |
Oates, HF; Stoker, LM | 1 |
Graham, RM; Oates, HF; Stokes, GS | 1 |
Hasegawa, K; Inoue, S; Kakumae, S; Kawahara, Y; Nakamura, T; Nakao, M; Nezuo, S; Sawayama, T; Tadaoka, S | 1 |
DeForrest, JM; Everett, DW; Migdalof, BH; Morrison, RA; Singhvi, SM; Weinstein, SH | 1 |
Wilson, JX | 1 |
Puschett, JB; Rastegar, A | 1 |
Anderson, RJ; Crumpler, CP; Hart, GR; Ram, CV | 1 |
Cavero, I | 1 |
Brunner, HR; Nussberger, J; Waeber, B | 1 |
Corvera, S; García-Sáinz, JA | 1 |
Guder, WG; Lefrank, S; Wirthensohn, G | 1 |
Chan, W; Espiner, EA; Ikram, H; Nicholls, MG | 1 |
Kaplan, HR; Smith, RD; Tessman, DK | 1 |
Cumming, AM; Leckie, BJ; McAreavey, D; Morton, JJ; Murray, GD; Robertson, JI; Sood, VP | 1 |
Chang, RS; Chen, TB; de Laszlo, SE; Faust, KA; Greenlee, WJ; Kivlighn, SS; Lotti, VJ; Patchett, AA; Quagliato, CS; Scheck, SA | 1 |
Eguchi, S; Hirata, Y; Inagami, T; Iwasaki, H; Kawakatsu, H; Marumo, F; Matsumoto, T; Motley, ED; Numaguchi, K; Owada, KM; Utsunomiya, H; Yamakawa, T | 1 |
Earp, HS; Graves, LM; Lee, JW; Li, X | 1 |
Nawrocka, W; Staśko, JJ | 1 |
Fukuda, N; Hu, WY; Izumi, Y; Kanmatsuse, K; Soma, M | 1 |
Brecher, P; Wang, D; Yu, X | 1 |
Eguchi, K; Eguchi, S; Frank, GD; Hirata, Y; Inagami, T; Iwasaki, H; Marumo, F; Motley, ED; Ueno, H | 1 |
Fujiyama, S; Higashiyama, S; Iba, O; Iwasaka, T; Jyo, N; Koyama, Y; Maruyama, K; Masaki, H; Matsubara, H; Mori, Y; Nose, A; Nozawa, Y; Ogata, N; Tateishi, E; Tsutsumi, Y; Uchiyama, Y | 1 |
Eguchi, S; Frank, GD; Inagami, T; Motley, ED | 1 |
Carmines, PK; Che, Q; Fallet, RW; Fujiwara, K | 1 |
Chen, CF; Hung, PH; Lin, LC; Wang, GJ; Wang, PS | 1 |
Higaki, J; Kamide, K; Moriguchi, K; Nagai, M; Ogihara, T; Ohishi, M; Okamura, A; Rakugi, H; Satoh, N; Tuck, ML | 1 |
Alberto Olivares-Reyes, J; Catt, KJ; Shah, BH; Yesilkaya, A | 1 |
Kawai, T; Koshimizu, T; Nasa, Y; Oshikawa, S; Shinoura, H; Sunada, S; Takeo, S; Tanoue, A; Tsujimoto, G | 1 |
Arakawa, K; Ideishi, M; Saku, K; Uehara, Y; Urata, H | 1 |
Carmines, PK; Che, Q | 1 |
Brandes, RP; Busse, R; Geiger, H; Jung, O; Pedrazzini, T; Schreiber, JG | 1 |
Chen, R; Morinelli, TA; Paul, RV; Ullian, ME; Webb, JG | 1 |
Kolachana, P; Lawsin, LM; Moore, J; Perlman, A; Ringel, MD; Saji, M | 1 |
Beaucage, P; Moreau, P | 1 |
Akhtar, S; Benboubetra, M; Benter, IF; Griffiths, SM; Yousif, MH | 1 |
Alagarsamy, S; Alexander, LD; Cui, XL; Ding, Y; Douglas, JG | 1 |
Andresen, BT; Escano, CS; Gutweiler, AA; Keever, LB | 1 |
Bae, YS; Catt, KJ; Choi, H; Hunyady, L; Leto, TL; Rhee, SG | 1 |
Chen, SY; Deng, SX; Li, D; Li, YJ; Liao, DF; Qin, XP; Ren, JF; Tian, HH; Zeng, SY; Zheng, YB | 1 |
Buharalioglu, CK; Malik, KU; Mugabe, BE; Song, CY; Waters, CM; Yaghini, FA | 1 |
Arellano-Plancarte, A; Catt, KJ; Hernandez-Aranda, J; Olivares-Reyes, JA | 1 |
Anand-Srivastava, MB; Gomez Sandoval, YH; Lévesque, LO | 1 |
Chen, XP; Hu, CP; Li, D; Li, TT; Li, YJ; Peng, J; Wang, CJ; Zhou, Z | 1 |
Balla, A; Balla, T; Erdélyi, LS; Hunyady, L; Soltész-Katona, E; Várnai, P | 1 |
Akhtar, S; Al-Farsi, O; Benter, IF; Chandrasekhar, B; Dhaunsi, GS; Yousif, MH | 1 |
Eguchi, S; Fujigaki, Y; Hishida, A; Suzuki, H; Yamamoto, T | 1 |
Iwao, H; Izumi, Y; Kita, H; Osada-Oka, M; Sato, T; Yagi, S | 1 |
Goto, S; Hirose, Y; Miyazaki, H; Nishijima, F; Niwa, T; Shimizu, H; Zghonda, N; Zrelli, H | 1 |
Gong, QH; Li, YJ; Sun, AS; Wu, Q; Yu, LM; Zhang, F | 1 |
Guo, QL; Song, ZB; Wu, H; Yan, JQ; Yang, Y | 1 |
Choi, E; Daugherty, A; Eguchi, S; Elliott, KJ; Forrester, SJ; Fukuda, Y; Kawai, T; Kobayashi, T; Obama, T; Rizzo, V; Takayanagi, T; Taro, Y; Tsuji, T | 1 |
Davisson, RL; Eguchi, S; Elliott, KJ; Forrester, SJ; Fukuda, Y; Kawai, T; Obama, T; Park, JY; Takayanagi, T; Tilley, DG; Tsuji, T | 1 |
Mishra, N; Nugent, WH; Strauss, JF; Walsh, SW | 1 |
Li, X; Liang, G; Liu, Z; Peng, K; Qian, Y; Skibba, M; Tian, X; Wang, J; Xu, Z; Zou, C | 1 |
Bao, Y; Hu, J; Lan, J; Li, X; Liang, G; Peng, K; Qian, Y; Skibba, M; Zhao, Y; Zhong, P | 1 |
Bordignon, V; da Rosa, PRA; De Cesaro, MP; Duggavathi, R; Gonçalves, PBD; Pereira Dau, AM | 1 |
Gao, L; Lu, HQ; Qin, XP; Yan, QJ; Yang, L; Zeng, SY | 1 |
1 review(s) available for angiotensin ii and quinazolines
Article | Year |
---|---|
New quinazolinones-4. Antiinflammatory and anticonvulsant agents. New classes of pharmacologically active compounds.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Humans; Quinazolines | 1998 |
57 other study(ies) available for angiotensin ii and quinazolines
Article | Year |
---|---|
Relationship between the hypotensive and alpha-adrenoceptor blocking actions of prazosin.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Male; Norepinephrine; Prazosin; Quinazolines; Rats | 1979 |
A new prazosin analogue BL-5111A.
Topics: Angiotensin II; Animals; Blood Pressure; Dose-Response Relationship, Drug; Epinephrine; Hemodynamics; Norepinephrine; Prazosin; Quinazolines; Rats | 1979 |
Mechanism of the hypotensive action of prazosin.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Diazoxide; Dose-Response Relationship, Drug; Drug Interactions; Epinephrine; Heart Rate; Hydralazine; Indoramin; Norepinephrine; Pentolinium Tartrate; Phentolamine; Prazosin; Quinazolines; Rats | 1977 |
[The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure].
Topics: Adrenergic alpha-Antagonists; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Quinazolines; Renin | 1989 |
Relationship between metabolism and pharmacologic activity of SQ 27,786, an angiotensin converting enzyme inhibitor with potent diuretic activity.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biotransformation; Blood Pressure; Bradykinin; Diuresis; Diuretics; Dogs; Female; Male; Proline; Quinazolines; Sulfur Radioisotopes | 1987 |
Conjugated catecholamines and pressor responses to angiotensin, luteinizing hormone-releasing hormone and prazosin in conscious toads.
Topics: Angiotensin II; Animals; Blood Pressure; Bufo marinus; Catecholamines; Dopamine; Dose-Response Relationship, Drug; Epinephrine; Female; Gonadotropin-Releasing Hormone; Male; Norepinephrine; Prazosin; Quinazolines | 1985 |
Comparative study of the effects of metolazone and other diuretics on potassium excretion.
Topics: Acetazolamide; Aldosterone; Aminohippuric Acids; Angiotensin II; Chlorothiazide; Diuretics; Ethacrynic Acid; Furosemide; Humans; Insulin; Kidney Tubules, Distal; Kidney Tubules, Proximal; Male; Natriuresis; Potassium; Quinazolines; Renin; Sodium | 1974 |
Alpha adrenergic blockade by prazosin in therapy of essential hypertension.
Topics: Adrenergic alpha-Antagonists; Adult; Angiotensin II; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Prazosin; Quinazolines | 1981 |
Effects of prazosin on reflex changes in heart rate evoked by vasopressor and vasodepressor stimuli in conscious rabbits.
Topics: Acetylcholine; Angiotensin II; Animals; Blood Pressure; Female; Heart Rate; Male; Phenylephrine; Prazosin; Quinazolines; Rabbits; Reflex | 1982 |
Blood pressure dependency on vasopressin and angiotensin II in prazosin-treated conscious normotensive rats.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Bradycardia; Catecholamines; Deamino Arginine Vasopressin; Heart Rate; Male; Methoxamine; Prazosin; Pressoreceptors; Quinazolines; Rats; Renin; Saralasin | 1983 |
Hypothyroidism abolishes the glycogenolytic effect of vasopressin, angiotensin II and A23187 but not that of alpha 1-adrenergic amines in rat hepatocytes.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Calcimycin; Epinephrine; Female; Hypothyroidism; Kinetics; Liver; Liver Glycogen; Prazosin; Quinazolines; Rats; Rats, Inbred Strains | 1983 |
Phospholipid metabolism in rat kidney cortical tubules. II. Effects of hormones on 32P incorporation.
Topics: Angiotensin II; Animals; Kidney Cortex; Kidney Tubules; Kinetics; Male; Parathyroid Hormone; Phenylephrine; Phospholipids; Phosphorus Radioisotopes; Prazosin; Quinazolines; Rats; Rats, Inbred Strains | 1984 |
A possible mechanism for "tachyphylaxis' to prazosin in heart failure.
Topics: Angiotensin II; Heart Diseases; Hemodynamics; Humans; Prazosin; Quinazolines; Renin; Tachycardia | 1980 |
Acute tolerance to prazosin in conscious hypertensive rats: involvement of the renin-angiotensin system.
Topics: Angiotensin II; Animals; Captopril; Cardiovascular Agents; Clonidine; Dose-Response Relationship, Drug; Drug Tolerance; Hydrochlorothiazide; Hypertension; Indomethacin; Male; Methyltyrosines; Prazosin; Propranolol; Quinazolines; Rats; Renin | 1981 |
The effect of oral prazosin on blood pressure and plasma concentrations of renin and angiotensin II in man.
Topics: Administration, Oral; Adult; Angiotensin II; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Prazosin; Quinazolines; Renin | 1981 |
A potent, orally active, balanced affinity angiotensin II AT1 antagonist and AT2 binding inhibitor.
Topics: Administration, Oral; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Binding Sites; Quinazolines; Rabbits; Rats; Receptors, Angiotensin; Renin-Angiotensin System | 1993 |
Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Aorta, Thoracic; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; GRB2 Adaptor Protein; Muscle, Smooth, Vascular; Nitriles; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases; Proteins; Proto-Oncogene Proteins pp60(c-src); Quinazolines; Rats; Rats, Sprague-Dawley; src Homology Domains; Tyrphostins | 1998 |
Angiotensin II stimulates ERK via two pathways in epithelial cells: protein kinase C suppresses a G-protein coupled receptor-EGF receptor transactivation pathway.
Topics: Angiotensin II; Animals; Cell Line; Enzyme Activation; Enzyme Inhibitors; Epidermal Growth Factor; Epithelial Cells; ErbB Receptors; GTP-Binding Proteins; Humans; Liver; Protein Kinase C; Protein-Tyrosine Kinases; Quinazolines; Rats; Recombinant Proteins; Signal Transduction; Tetradecanoylphorbol Acetate; Transcriptional Activation | 1998 |
Bunazosin hydrochloride inhibits exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats by suppressing the response to growth factors.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Cell Division; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Epidermal Growth Factor; Growth Inhibitors; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Quinazolines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger | 1998 |
Nitric oxide inhibits angiotensin II-induced activation of the calcium-sensitive tyrosine kinase proline-rich tyrosine kinase 2 without affecting epidermal growth factor receptor transactivation.
Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Angiotensin II; Animals; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; ErbB Receptors; Focal Adhesion Kinase 2; Indoles; Maleimides; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Nitric Oxide; Nitroprusside; Phosphorylation; Protein-Tyrosine Kinases; Proteins; Quinazolines; Rats; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; Transcriptional Activation; Tyrphostins | 1999 |
Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser(411) in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt.
Topics: Angiotensin II; Animals; Calcium; CHO Cells; Cricetinae; ErbB Receptors; Muscle, Smooth, Vascular; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quinazolines; ras Proteins; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases; Serine; Transcriptional Activation; Tyrphostins | 1999 |
Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Topics: Angiopoietin-1; Angiopoietin-2; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium; Cells, Cultured; Cornea; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Gene Expression Regulation; Heparin-binding EGF-like Growth Factor; Imidazoles; In Vitro Techniques; Indoles; Intercellular Signaling Peptides and Proteins; Lymphokines; Maleimides; Membrane Glycoproteins; Naphthalenes; Neovascularization, Physiologic; Olmesartan Medoxomil; Protein Kinase C; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases; Proteins; Pyridines; Quinazolines; Rabbits; Rats; Receptor Protein-Tyrosine Kinases; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, TIE-2; Receptors, Angiotensin; Receptors, Cell Surface; Receptors, TIE; RNA Stability; RNA, Messenger; Tetrazoles; Time Factors; Transcriptional Activation; Tyrphostins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
N-acetylcysteine inhibits angiotensin ii-mediated activation of extracellular signal-regulated kinase and epidermal growth factor receptor.
Topics: Acetylcysteine; Angiotensin II; Animals; Antioxidants; Blotting, Western; Calcimycin; Dose-Response Relationship, Drug; Enzyme Activation; ErbB Receptors; Hydrogen Peroxide; Immunoblotting; Ionophores; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth; Phosphorylation; Precipitin Tests; Pyrimidines; Quinazolines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Time Factors; Transcriptional Activation; Tyrphostins | 2001 |
Tyrosine kinase involvement in renal arteriolar constrictor responses to angiotensin II.
Topics: Angiotensin II; Animals; Enalaprilat; Enzyme Inhibitors; ErbB Receptors; In Vitro Techniques; Male; Microscopy, Video; Perfusion; Phosphorylation; Protein-Tyrosine Kinases; Quinazolines; Rats; Rats, Sprague-Dawley; Renal Artery; Signal Transduction; Tyrphostins; Vasoconstriction | 2001 |
Inhibitory effect of evodiamine on aldosterone release by Zona glomerulosa cells in male rats.
Topics: Aldosterone; Angiotensin II; Animals; Male; Mineralocorticoid Receptor Antagonists; Plant Extracts; Quinazolines; Rats; Rats, Sprague-Dawley; Zona Glomerulosa | 2001 |
The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Catecholamines; Diet; Fructose; Glucose Tolerance Test; Heart Rate; Hydralazine; Hyperinsulinism; Hypertrophy, Left Ventricular; Imidazoles; Insulin; Male; Myocardium; Olmesartan Medoxomil; Organ Size; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Renin-Angiotensin System; Sympathetic Nervous System; Tetrazoles | 2002 |
Independence of angiotensin II-induced MAP kinase activation from angiotensin type 1 receptor internalization in clone 9 hepatocytes.
Topics: Angiotensin II; Animals; Arsenicals; Cell Line; Concanavalin A; COS Cells; Endocytosis; Enzyme Activation; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Gene Expression; Hepatocytes; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Quinazolines; Rats; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Sucrose; Transfection; Tyrphostins | 2002 |
The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Aorta; Arteries; Blood Pressure; Cardiovascular System; Female; Gene Targeting; In Vitro Techniques; Male; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Piperazines; Quinazolines; Radioligand Assay; Receptors, Adrenergic, alpha-1; Serotonin; Tissue Extracts; Vasoconstriction; Vasoconstrictor Agents; Vasopressins | 2002 |
Chymase inhibition suppresses high-cholesterol diet-induced lipid accumulation in the hamster aorta.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Animals; Aorta; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Chymases; Cricetinae; Male; Mesocricetus; Peptidyl-Dipeptidase A; Quinazolines; Regression Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serine Endopeptidases; Serine Proteinase Inhibitors; Triglycerides; Tunica Intima | 2002 |
Angiotensin II triggers EGFR tyrosine kinase-dependent Ca2+ influx in afferent arterioles.
Topics: Angiotensin II; Animals; Arterioles; Calcium; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; Fluorescent Dyes; Fura-2; In Vitro Techniques; Intracellular Fluid; Kidney; Male; Manganese; Protein Tyrosine Phosphatases; Quinazolines; Rats; Rats, Sprague-Dawley; Tyrphostins | 2002 |
gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Acetylcholine; Angiotensin II; Animals; Antioxidants; Aorta; Bacterial Toxins; Cardiomyopathy, Hypertrophic; Cytochromes b; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; ErbB Receptors; Glycoproteins; Hypertension, Renovascular; Indoles; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 2; NADPH Oxidases; Nitric Oxide; Organ Culture Techniques; Polyethylene Glycols; Protein Kinase C; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Quinazolines; Superoxide Dismutase; Superoxides; Tyrphostins; Vasodilation; Vasodilator Agents | 2004 |
Mechanisms of vascular angiotensin II surface receptor regulation by epidermal growth factor.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Cells, Cultured; Cytochalasin D; Dactinomycin; Down-Regulation; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Ligands; Muscle, Smooth, Vascular; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Tyrphostins | 2004 |
Angiotensin II regulation of TGF-beta in murine mesangial cells involves both PI3 kinase and MAP kinase.
Topics: Angiotensin II; Animals; Butadienes; Cell Line; Chromones; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Inhibitors; Epidermal Growth Factor; Glomerular Mesangium; Immunoblotting; Losartan; Mice; Mitogen-Activated Protein Kinase Kinases; Morpholines; Nitriles; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Quinazolines; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta; Tyrphostins | 2004 |
EGF receptor transactivation in angiotensin II and endothelin control of vascular protein synthesis in vivo.
Topics: Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Endothelins; ErbB Receptors; Heart Rate; Hypertension; Infusion Pumps, Implantable; Mesenteric Arteries; Protein Biosynthesis; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Sprague-Dawley; Signal Transduction; Tyrphostins | 2004 |
Epidermal growth factor receptor tyrosine kinase-mediated signalling contributes to diabetes-induced vascular dysfunction in the mesenteric bed.
Topics: Angiotensin II; Animals; Carbachol; Cell Line; Diabetes Mellitus, Experimental; Endothelin-1; ErbB Receptors; Female; Genistein; Histamine; Humans; In Vitro Techniques; Mesenteric Arteries; Mesenteric Veins; Norepinephrine; Quinazolines; Rats; Rats, Wistar; Signal Transduction; Streptozocin; Tyrphostins; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2005 |
Arachidonic acid induces ERK activation via Src SH2 domain association with the epidermal growth factor receptor.
Topics: Angiotensin II; Animals; Arachidonic Acid; Cells, Cultured; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; Glutathione Transferase; Kidney Tubules, Proximal; Kinetics; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Protein Structure, Tertiary; Proto-Oncogene Proteins pp60(c-src); Pyrimidines; Quinazolines; Rabbits; Recombinant Fusion Proteins; Transcriptional Activation; Tyrphostins | 2006 |
Angiotensin II activates extracellular signal-regulated kinase independently of receptor tyrosine kinases in renal smooth muscle cells: implications for blood pressure regulation.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Blood Pressure; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Epidermal Growth Factor; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Kidney; Myocytes, Smooth Muscle; Platelet-Derived Growth Factor; Protein Tyrosine Phosphatases; Quinazolines; Rats; Rats, Inbred WKY; Receptor Protein-Tyrosine Kinases; Receptors, Platelet-Derived Growth Factor; Tyrphostins; Vasoconstrictor Agents | 2008 |
Mechanism of angiotensin II-induced superoxide production in cells reconstituted with angiotensin type 1 receptor and the components of NADPH oxidase.
Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Androstadienes; Angiotensin II; Animals; Cell Line; CHO Cells; Chromones; Cricetinae; Cricetulus; Gene Expression; Humans; Indoles; Maleimides; Membrane Glycoproteins; Morpholines; Mutation; NADPH Oxidase 1; NADPH Oxidase 2; NADPH Oxidases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphoproteins; Protein Kinase C; Pyrazoles; Pyrimidines; Quinazolines; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; Superoxides; Tyrphostins; Wortmannin | 2008 |
Involvement of prolylcarboxypeptidase in the effect of rutaecarpine on the regression of mesenteric artery hypertrophy in renovascular hypertensive rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Carboxypeptidases; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension, Renovascular; Hypertrophy; Indole Alkaloids; Kallikreins; Losartan; Male; Mesenteric Arteries; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Quinazolines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Up-Regulation | 2009 |
Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Butadienes; Cell Culture Techniques; Cell Migration Assays; Cell Movement; Cells, Cultured; CSK Tyrosine-Protein Kinase; Enzyme Inhibitors; Epidermal Growth Factor; Extracellular Signal-Regulated MAP Kinases; Intracellular Signaling Peptides and Proteins; Male; Muscle, Smooth, Vascular; Nitriles; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein-Tyrosine Kinases; Quinazolines; Rats; Rats, Sprague-Dawley; src-Family Kinases; Syk Kinase; Transcriptional Activation; Tyrphostins | 2010 |
Angiotensin-induced EGF receptor transactivation inhibits insulin signaling in C9 hepatic cells.
Topics: Angiotensin II; Animals; Cell Line; Enzyme Inhibitors; ErbB Receptors; Hepatocytes; Insulin; Insulin Resistance; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinazolines; Rats; Receptor, Insulin; Serine; Signal Transduction; Threonine; Transcriptional Activation; Tyrphostins; Vasoconstrictor Agents | 2010 |
Contribution of epidermal growth factor receptor transactivation in angiotensin II-induced enhanced expression of Gi protein and proliferation in A10 vascular smooth muscle cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Blotting, Western; Cell Line; Cell Proliferation; ErbB Receptors; GTP-Binding Protein alpha Subunits, Gi-Go; Imidazoles; Losartan; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Pyridines; Quinazolines; Rats; Receptors, Angiotensin; Transcriptional Activation; Tyrphostins | 2009 |
Accelerated senescence of endothelial progenitor cells in hypertension is related to the reduction of calcitonin gene-related peptide.
Topics: Adult; Adult Stem Cells; Angiotensin II; Animals; Base Sequence; Calcitonin Gene-Related Peptide; Capsaicin; Cellular Senescence; DNA Primers; Endothelial Cells; Female; Humans; Hypertension; In Vitro Techniques; Indole Alkaloids; Male; Middle Aged; Quinazolines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; TRPV Cation Channels | 2010 |
Demonstration of angiotensin II-induced Ras activation in the trans-Golgi network and endoplasmic reticulum using bioluminescence resonance energy transfer-based biosensors.
Topics: Angiotensin II; Arrestins; beta-Arrestins; Biosensing Techniques; Endoplasmic Reticulum; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; HEK293 Cells; Humans; Luminescent Measurements; Oncogene Protein p21(ras); Quinazolines; Receptor, Angiotensin, Type 1; Signal Transduction; trans-Golgi Network; Tyrphostins | 2011 |
Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway.
Topics: Angiotensin I; Angiotensin II; Animals; Body Weight; Diabetes Mellitus; ErbB Receptors; Glucose; Hyperglycemia; Male; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Quinazolines; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; src-Family Kinases; Transcriptional Activation; Tyrphostins | 2012 |
Comparison of ROCK and EGFR activation pathways in the progression of glomerular injuries in AngII-infused rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin II; Animals; Disease Progression; ErbB Receptors; Gefitinib; Kidney Diseases; Kidney Glomerulus; Male; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Wistar; rho-Associated Kinases; Signal Transduction | 2011 |
Angiotensin AT1 receptor blockers suppress oxidized low-density lipoprotein-derived formation of foam cells.
Topics: Acetyl-CoA C-Acetyltransferase; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Cholesterol Esters; Enzyme Inhibitors; ErbB Receptors; Foam Cells; Heparin-binding EGF-like Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Lipoproteins, LDL; Losartan; Macrophages; Quinazolines; Tetrazoles; Triglycerides; Tyrphostins | 2012 |
Indoxyl sulfate enhances angiotensin II signaling through upregulation of epidermal growth factor receptor expression in vascular smooth muscle cells.
Topics: Acetylcysteine; Angiotensin II; Animals; Arteriosclerosis; Cells, Cultured; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Indican; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Quinazolines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Tyrphostins; Up-Regulation | 2012 |
Rutaecarpine inhibits angiotensin II-induced proliferation in rat vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Base Sequence; Cell Proliferation; Cells, Cultured; DNA Primers; Hemeproteins; Indole Alkaloids; Male; Muscle, Smooth, Vascular; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-myc; Quinazolines; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction | 2014 |
Tumor necrosis factor-α inhibits angiotensin II receptor type 1 expression in dorsal root ganglion neurons via β-catenin signaling.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; beta Catenin; Chromans; Dactinomycin; Dose-Response Relationship, Drug; Ganglia, Spinal; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Imidazoles; Indoles; Male; Neurons; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Quinazolines; Rats; Receptor, Angiotensin, Type 1; RNA, Messenger; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha | 2013 |
Epidermal growth factor receptor inhibitor protects against abdominal aortic aneurysm in a mouse model.
Topics: Aminopropionitrile; Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Rupture; Cells, Cultured; Cytoprotection; Disease Models, Animal; Endoplasmic Reticulum Stress; ErbB Receptors; Erlotinib Hydrochloride; Extracellular Matrix; Humans; Interleukin-6; Male; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidative Stress; Protein Kinase Inhibitors; Quinazolines; Rats, Sprague-Dawley; Time Factors | 2015 |
Role of epidermal growth factor receptor and endoplasmic reticulum stress in vascular remodeling induced by angiotensin II.
Topics: ADAM Proteins; ADAM17 Protein; Angiotensin II; Animals; Disease Models, Animal; Endoplasmic Reticulum Stress; Endothelium, Vascular; ErbB Receptors; Erlotinib Hydrochloride; Hypertension; Hypertrophy; Mice; Muscle, Smooth, Vascular; Phenylbutyrates; Quinazolines; Random Allocation; Role; Sensitivity and Specificity; Signal Transduction; Vascular Remodeling | 2015 |
Matrix Metalloproteinase 1 Causes Vasoconstriction and Enhances Vessel Reactivity to Angiotensin II via Protease-Activated Receptor 1.
Topics: Adult; Angiotensin II; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Matrix Metalloproteinase 1; Omentum; Organ Culture Techniques; Pre-Eclampsia; Pregnancy; Pyrroles; Quinazolines; Receptor, PAR-1; Vasoconstriction; Young Adult | 2016 |
Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiotonic Agents; Cell Line; Drug Evaluation, Preclinical; Epidermal Growth Factor; ErbB Receptors; Gene Knockdown Techniques; Mice, Inbred C57BL; Myocytes, Cardiac; Quinazolines; Rats; Tyrphostins | 2016 |
New EGFR inhibitor, 453, prevents renal fibrosis in angiotensin II-stimulated mice.
Topics: Angiotensin II; Animals; Apoptosis; ErbB Receptors; Fibrosis; Kidney; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Protein Kinase Inhibitors; Quinazolines; Tyrphostins | 2016 |
Reversible meiotic arrest of bovine oocytes by EGFR inhibition and follicular hemisections.
Topics: Angiotensin II; Animals; Cattle; Cell Cycle Checkpoints; Cumulus Cells; Dinoprostone; Embryo Culture Techniques; ErbB Receptors; Female; Follicle Stimulating Hormone; Gene Expression Regulation; Granulosa Cells; In Vitro Oocyte Maturation Techniques; Meiosis; Oocytes; Ovarian Follicle; Quinazolines; RNA, Messenger; Signal Transduction; Tyrphostins | 2017 |
Rutaecarpine prevents hypertensive cardiac hypertrophy involving the inhibition of Nox4-ROS-ADAM17 pathway.
Topics: ADAM17 Protein; Angiotensin II; Animals; Aorta, Abdominal; Cardiomegaly; Constriction, Pathologic; Gene Expression Regulation; Humans; Hypertension; Indole Alkaloids; MAP Kinase Signaling System; Myocytes, Cardiac; NADPH Oxidase 4; Quinazolines; Rats; Rats, Inbred Dahl; Reactive Oxygen Species | 2019 |